Litecoat Aspirin Interactions
There are 347 drugs known to interact with Litecoat Aspirin (aspirin), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 54 are major, 247 are moderate, and 46 are minor.
- View all 347 medications that may interact with Litecoat Aspirin
- View Litecoat Aspirin alcohol/food interactions (2)
- View Litecoat Aspirin disease interactions (9)
Most frequently checked interactions
View interaction reports for Litecoat Aspirin (aspirin) and the medicines listed below.
- acetaminophen
- Actos (pioglitazone)
- albuterol / ipratropium
- alpha-lipoic acid
- Ambien (zolpidem)
- Benadryl (diphenhydramine)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- carbidopa / levodopa
- citalopram
- Claritin 24 Hour Allergy (loratadine)
- Coenzyme Q10 (ubiquinone)
- cyanocobalamin
- diclofenac
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- folic acid
- furosemide
- Klonopin (clonazepam)
- lactulose
- Lecithin-Softgels (lecithin)
- levothyroxine
- lisinopril
- Lopid (gemfibrozil)
- magnesium citrate
- meloxicam
- metformin
- methadone
- Methotrexate LPF Sodium (methotrexate)
- nitroglycerin
- potassium chloride
Litecoat Aspirin alcohol/food interactions
There are 2 alcohol/food interactions with Litecoat Aspirin (aspirin).
Litecoat Aspirin disease interactions
There are 9 disease interactions with Litecoat Aspirin (aspirin) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Litecoat Aspirin (aspirin)
- Compare alternatives
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.